Back to top
more

Amedisys (AMED)

(Delayed Data from NSDQ)

$96.80 USD

96.80
523,757

-0.91 (-0.93%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $96.80 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 23% (58 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks News

Tirthankar Chakraborty headshot

New Strong Buy Stocks for January 24th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

Has Amedisys (AMED) Outpaced Other Medical Stocks This Year?

Is (AMED) Outperforming Other Medical Stocks This Year?

The Zacks Analyst Blog Highlights: MagnaChip Semiconductor, Ichor, Chico's FAS, Amedisys and PBF Logistics

The Zacks Analyst Blog Highlights: MagnaChip Semiconductor, Ichor, Chico's FAS, Amedisys and PBF Logistics

Zacks.com featured highlights include: SYNNEX, MagnaChip Semiconductor, Delta Air Lines, Amedisys and Forterra

Zacks.com featured highlights include: SYNNEX, MagnaChip Semiconductor, Delta Air Lines, Amedisys and Forterra

Nalak Das headshot

5 Top Stocks That Popped in 2020 and Have Strong Upside Left

It seems that Wall Street bulls have no intention of taking a breather after completing the best year in the last six years.

Nilanjan Choudhury headshot

Invest in These 5 Stocks With Solid Relative Price Strength

Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

Elanco (ELAN) Surges: Stock Moves 5.3% Higher

Elanco (ELAN) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

3 Reasons Growth Investors Will Love Amedisys (AMED)

Amedisys (AMED) possesses solid growth attributes, which could help it handily outperform the market.

Invest in These 5 Low Leverage Stocks Before Q4 Earnings

Companies displaying high earnings growth along with high leverage ratios should be avoided while making investment decisions. So, investors should select companies with low leverage.

Job Additions Top 2 Million Mark Again in 2019: 5 Winners

In 2019, 2.1 million employees were added. Here are five stocks that can benefit the most from healthy job additions from the top-gaining sectors.

Sumit Singh headshot

These 5 Stocks Boast Impressive Interest Coverage Ratio

A company's creditworthiness depends on how effectively it meets interest obligations. One that is capable of generating earnings well above its interest expense can withstand financial hardships.

Amedisys (AMED) Hits Fresh High: Is There Still Room to Run?

Amedisys (AMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Amedisys (AMED) Upgraded to Strong Buy: What Does It Mean for the Stock?

Amedisys (AMED) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Amedisys Gains on Favorable Demography, New Hospice Buyouts

Amedisys (AMED) is steadily benefiting from its recent takeovers of hospice care providers, namely RoseRock Healthcare and Compassionate Care Hospice.

Amedisys Completes Asana Hospice Acquisition, Expands Network

Amedisys (AMED) closes Asana takeover to strengthen its hospice care network.

Debanjana Dey headshot

7 Impressive Growth Stocks to Buy for 2020

The prospects of growth stocks appear bright for 2020, making the following companies attractive bets.

Trina Mukherjee headshot

Rosy Outlook for Outpatient and Home Healthcare Industry

Growth prospects look bright for the Zacks Outpatient and Home Healthcare industry, thanks to AI, cost effectiveness and participation in APM.

Cigna to Divest Non-Health Unit, Streamline Operations

Cigna (CI) announces sale of its Group Life and Disability business to focus on debt reduction and core business of healthcare.

The Zacks Analyst Blog Highlights: Amedisys, Select Medical Holdings, LHC, Eurofins Scientific and DaVita

The Zacks Analyst Blog Highlights: Amedisys, Select Medical Holdings, LHC, Eurofins Scientific and DaVita

Sapna Bagaria headshot

5 Healthcare Stocks to Keep the Winning Streak Alive in 2020

Increasing incidence of chronic diseases, aging U.S. population, innovation and consolidation will drive the healthcare industry's growth in 2020.

Amedisys (AMED) Benefits From Home Health and Personal Care

Amedisys' (AMED) impressive performance in the newly-unveiled Personal Care segment is appreciative.

Teladoc Adds to its Services With Tailored Nutrition Plans

Teladoc (TDOC) enhances its service portfolio with the addition of personalized diet programs.

Amedisys (AMED) Up 24.8% Since Last Earnings Report: Can It Continue?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks.com featured highlights include: Amedisys, PC Connection, NRG and Target

Zacks.com featured highlights include: Amedisys, PC Connection, NRG and Target

Amedisys (AMED) to Broaden Hospice Base With Asana Purchase

Asana's acquisition to be the third hospice care buyout of Amedisys (AMED) in 2019.